ENHA logo

ENHANCED GROUP INC

ENHANYSE
πŸ† #2233 by market capEarnings Sep 2US Equity
$2.15β–Ό $0.28 (βˆ’12.96%)
πŸŒ… Pre-market$2.27β–² 5.58%Regular close Β· extended-hours price shown
1hβ€”
24hβ–Ό 13.0%
7dβ–Ό 20.1%
14dβ–Ό 19.5%
30dβ–Ό 17.9%
1yβ€”
🏦Market Cap
$820M
Small Cap
πŸ“ˆRevenue Growth (YoY)
β€”
πŸ“ŠGross Margin
β€”
πŸ’΅FCF Margin
β€”
βš–οΈP/S Ratio
β€”
Otter Score
58
Weak

Trading Snapshot

Day Range
$2.13 – $2.19
52-Week Range
$2.35 – $10.17
Volume
$2.64B
Avg Volume
$2.53B
Shares Outstanding
381.4M
Next Earnings
Sep 9, 2026

Fundamentals Snapshot

Annual Revenue
$81M
Last Q Revenue
$2,755
P/E Ratio
241.0
P/S Ratio
β€”
EPS (TTM)
$0.17
Dividend Yield
β€”

Why Investors Own ENHA

  • βœ“High-growth profile β€” revenue up +14.3% YoY with expanding US Equity exposure.
  • βœ“Healthy economics β€” 47% gross margin and 23% free-cash-flow margin.
  • βœ“New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

Financial Trends

Revenue (TTM)
$81Mβ–² +8.9% YoY
Gross Margin (TTM)
47.4%β–² +3.0% YoY
Operating Income (TTM)
$22Mβ–² +8.9% YoY
Free Cash Flow (TTM)
$19Mβ–² +8.9% YoY

About ENHANCED GROUP INC

Enhanced Group Inc. (ENHA) is a specialized firm dedicated to the competitive sports sector, providing advanced performance products. Its mission is to furnish athletes and general consumers with essential items designed to promote optimal health, boost athletic capabilities, and facilitate efficient recovery. The company's diverse portfolio extends beyond mere products, encompassing unique experiences that skillfully blend the thrill of athletic contests with cutting-edge scientific advancements and strong customer interaction. Enhanced Group's central operations are located in New York, NY.

🦦

Otter Score Breakdown

β“˜
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
Overall Score
Weak
58/100

Analyst Price Target

β“˜
Average Target
$2.68
β–² +24.4% Upside
High Target$3.04
Low Target$2.39
Based on 12 analysts

Latest News & Updates